These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 39181316)

  • 1. The regulatory mechanisms of N6-methyladenosine modification in ferroptosis and its implications in disease pathogenesis.
    Tao X; Kang N; Zheng Z; Zhu Z; Ma J; He W
    Life Sci; 2024 Oct; 355():123011. PubMed ID: 39181316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential roles of RNA N6-methyladenosine in atherosclerosis.
    Chen LH; Zhao YY; Huang L; Li YZ; Xu HQ; Yang C; Zhang C
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1075-1083. PubMed ID: 35253196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-methyladenosine (m6A) RNA modification in the pathophysiology of heart failure: a narrative review.
    Liu S; Wang T; Cheng Z; Liu J
    Cardiovasc Diagn Ther; 2022 Dec; 12(6):908-925. PubMed ID: 36605077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis: a critical mechanism of N
    Wei Q; Xue C; Li M; Wei J; Zheng L; Chen S; Duan Y; Deng H; Tang F; Xiong W; Zhou M
    Sci China Life Sci; 2024 Jun; 67(6):1119-1132. PubMed ID: 38811442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL14-Mediated m6A Modification of
    Gu X; Song Y; Liu X; Cheng Z; Min J; Zhang Y
    Front Biosci (Landmark Ed); 2024 Aug; 29(8):298. PubMed ID: 39206905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m6A control programmed cell death in cardiac fibrosis.
    Liu ZY; You QY; Liu ZY; Lin LC; Yang JJ; Tao H
    Life Sci; 2024 Sep; 353():122922. PubMed ID: 39032691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the role of N6-methyladenosine in ferroptosis.
    Zhang J; Qiu T; Yao X; Sun X
    Biomed Pharmacother; 2023 Sep; 165():115192. PubMed ID: 37487443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALKBH5 Modulates Asthma Progression by Downregulating N6-methyladenosine Methylation.
    Fan X; Wei C; Han Y
    Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):211-219. PubMed ID: 38822515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL4 mediated-N6-methyladenosine promotes acute lung injury by activating ferroptosis in alveolar epithelial cells.
    Sang A; Zhang J; Zhang M; Xu D; Xuan R; Wang S; Song X; Li X
    Free Radic Biol Med; 2024 Mar; 213():90-101. PubMed ID: 38224757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Advances in the Roles of N6-Methyladenosine Modification in Ovarian Cancer.
    Zhang Y; Ling Y; Zhou Y; Shi X; Shen F; Zhou J; Chen Y; Yang F; Gu Y; Wang J
    Cancer Control; 2024; 31():10732748241256819. PubMed ID: 38755968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
    Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
    Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
    Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of N6-methyladenosine with viruses and related diseases.
    Wu F; Cheng W; Zhao F; Tang M; Diao Y; Xu R
    Virol J; 2019 Nov; 16(1):133. PubMed ID: 31711514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine (m6A) modification in gynecological malignancies.
    Zhang C; Liu N
    J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
    Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
    BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into N6-methyladenosine and programmed cell death in cancer.
    Liu L; Li H; Hu D; Wang Y; Shao W; Zhong J; Yang S; Liu J; Zhang J
    Mol Cancer; 2022 Jan; 21(1):32. PubMed ID: 35090469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A RNA Methylation and Implications for Hepatic Lipid Metabolism.
    Ming X; Chen S; Li H; Wang Y; Zhou L; Lv Y
    DNA Cell Biol; 2024 Jun; 43(6):271-278. PubMed ID: 38635960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.